ClinicalTrials.gg
Active, not recruitingNCT07947719Updated Nov 19, 2026

Spiritual Reminiscence-Based Psychoeducation for Depression and Spiritual Well-Being in Older Adults

An interventional study of Spiritual Reminiscence Therapy-Based Psychoeducation in Spiritual Well-being and Depressive Symptoms, sponsored by Ataturk University. Active, not recruiting at 2 sites in Turkey (Türkiye). Open to participants aged 65 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-19.

Sponsored by Ataturk University · Not applicable, Interventional, and Treatment

How we know

Updated Nov 19, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
70
Allocation
Randomized
Ages
65 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-20

Among 11 studies in Depression by Ataturk University — 6 open to participants now, 7 under way, none of them phase 3. Depression · Ataturk University.

Enrollment
4th of 11
70 · median 69
Started
2026
with 1 other
No phase
11 of 11
6 open now
Registered
11th of 11
by date

Among the 11 studies in Depression by Ataturk University, this one is the 4th largest by enrollment, is one of 2 that started in 2026, is one of 11 with no phase, and was the 11th registered.

Depression

8,605 studies on the registry are indexed under Depression; 1,735 are open to participants now.

Browse Depression studies →

Open to participants now

6 of the 11 studies in Depression by Ataturk University are open now, in 1 country. Recruiting first, the newest first:

1 more — sign in →

By country, each count listing its studies:

All 6 open studies →

Where they have run

Who these studies take

Of the 1,099 Depression studies recruiting now, 474 (43%) set no upper age limit and 524 (48%) stop at 75 or younger; 205 take children under 18; 315 take healthy volunteers.

This study: 65 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 11 studies in Depression by Ataturk University, or all of them as a file.
02

Study summary

This study examines whether a psychoeducation program based on spiritual reminiscence therapy improves spiritual well-being and reduces depressive symptoms in adults aged 65 years and older living in nursing homes in Türkiye. Spiritual reminiscence involves reflecting on past experiences, personal values, beliefs, and relationships that give life meaning.

The intervention consists of 12 small-group sessions delivered twice a week over six weeks. Each session lasts approximately 40-50 minutes and is led by the researcher. Participants discuss meaningful life experiences, relationships, losses, worries, sources of strength, personal beliefs, and hopes for the future. Activities include sharing memories and meaningful objects, reflecting on past ways of coping with difficulties, and identifying achievable goals. Participants in the control group continue to receive the nursing home's usual care.

Spiritual well-being and depressive symptoms are assessed before the program, immediately after the program, and one month after its completion. The study compares the intervention and control groups to determine whether the program improves spiritual well-being and reduces depressive symptoms, and whether any benefits remain at the one-month follow-up.

Read the detailed description

This study investigates the effects of spiritual reminiscence therapy-based psychoeducation on spiritual well-being and depressive symptoms among older adults living in nursing homes. The program provides a structured opportunity to reflect on meaningful life experiences and explore personal sources of meaning, connection, and hope.

The intervention is organized around six themes, each addressed in two group sessions: meaning in life; loneliness and connection; fears and hope; physical changes and transcendence; spiritual resources and beliefs; and reconciliation with the past and sharing life wisdom. The program comprises 12 sessions delivered twice weekly over six weeks, with each session lasting approximately 40-50 minutes.

Sessions include guided reminiscence, sharing meaningful memories and objects, discussion of changes in social roles and relationships, and reflection on previous ways of coping with difficult experiences. Participants are encouraged to identify sources of support and consider small, achievable goals. Spirituality is approached through participants' own beliefs, values, and sources of meaning rather than through a prescribed religious perspective.

The researcher facilitates the sessions using active listening, supportive communication, and structured discussion. The control group continues to receive routine care provided by the nursing home.

Spiritual well-being is assessed using the Functional Assessment of Chronic Illness Therapy-Spiritual Well-Being 12-item scale (FACIT-Sp-12). Depressive symptoms are assessed using the 15-item Geriatric Depression Scale (GDS-15). Assessments are conducted at baseline, immediately after the intervention, and one month after intervention completion. The study evaluates differences between groups over time and whether any observed benefits persist at the one-month follow-up.

03

Conditions studied

  • Spiritual Well-being
  • Depressive Symptoms

Browse trials for

Keywords

  • Spiritual Reminiscence Therapy
  • Reminiscence Therapy
  • Psychoeducation
  • Older Adults
  • Nursing Homes
  • Psychiatric Nursing
04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged 65 years or older
  • Residing in one of the participating nursing homes
  • Willing to participate and providing written .
  • Able to communicate in Turkish.
  • A score of 24 or higher on the Standardized .

Exclusion criteria

Exclusion Criteria:

  • A diagnosis of severe depression or a psychotic disorder.
  • Hearing or visual impairment severe enough to prevent participation in the intervention.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
70 participants (actual)

Study arms

  • Experimental
    Spiritual Reminiscence-Based Psychoeducation

    Participants receive spiritual reminiscence therapy-based psychoeducation in small groups. The program consists of 12 sessions delivered twice weekly over six weeks, with each session lasting approximately 40-50 minutes.

    Behavioral: Spiritual Reminiscence Therapy-Based Psychoeducation

  • No intervention
    Usual Care

    Participants continue to receive routine care provided by the nursing home and do not receive the study's spiritual reminiscence therapy-based psychoeducation during the intervention and one-month follow-up period.

Interventions

  • BehavioralSpiritual Reminiscence Therapy-Based Psychoeducation

    A structured psychoeducation program facilitated by the researcher using guided reminiscence, active listening, and supportive discussion. The program addresses meaning in life, loneliness and relationships, fears and hope, physical changes associated with aging, personal spiritual resources, and reconciliation with the past. Activities include recalling meaningful experiences, sharing memories and meaningful objects, reflecting on previous coping strategies, and identifying achievable goals.

06

What researchers measure

Primary outcomes

  1. Spiritual Well-Being at the End of the Intervention Assessed With the FACIT-Sp-12

    Spiritual well-being will be assessed using the Turkish version of the Functional Assessment of Chronic Illness Therapy-Spiritual Well-Being 12-item scale (FACIT-Sp-12). Items are rated from 0 to 4. After reverse scoring the negatively worded items, item scores are summed to obtain a total score ranging from 0 to 48. Higher scores indicate greater spiritual well-being. Total scores at the end of the intervention will be compared between the intervention and control groups. Baseline scores are collected before the intervention.

    Time frame: Immediately after completion of the 6-week intervention.

Secondary outcomes

  1. Spiritual Well-Being at One-Month Follow-Up Assessed With the FACIT-Sp-12

    Spiritual well-being will be assessed using the Turkish version of the Functional Assessment of Chronic Illness Therapy-Spiritual Well-Being 12-item scale (FACIT-Sp-12). The total score is calculated by summing the 12 item scores after reverse scoring the negatively worded items. Total scores range from 0 to 48, with higher scores indicating greater spiritual well-being. Total scores at one-month follow-up will be compared between the intervention and control groups to evaluate whether an intervention effect remains after program completion.

    Time frame: One month after completion of the 6-week intervention.

  2. Depressive Symptoms at the End of the Intervention Assessed With the GDS-15

    Depressive symptoms will be assessed using the Turkish version of the 15-item Geriatric Depression Scale (GDS-15). The scale contains 15 yes/no items. Each response indicating a depressive symptom is scored 1; other responses are scored 0. Item scores are summed to obtain a total score ranging from 0 to 15. Higher scores indicate more depressive symptoms. Total scores at the end of the intervention will be compared between the intervention and control groups. Baseline scores are collected before the intervention.

    Time frame: Immediately after completion of the 6-week intervention.

  3. Depressive Symptoms at One-Month Follow-Up Assessed With the GDS-15

    Depressive symptoms will be assessed using the Turkish version of the 15-item Geriatric Depression Scale (GDS-15). Each response indicating a depressive symptom is scored 1; other responses are scored 0. Total scores range from 0 to 15, with higher scores indicating more depressive symptoms. Total scores at one-month follow-up will be compared between the intervention and control groups to evaluate whether an intervention effect remains after program completion.

    Time frame: One month after completion of the 6-week intervention.

07

Study locations

2 sites
  • Kahramanmaraş Huzurevi Yaşlı Bakım ve Rehabilitasyon Merkezi
    Kahramanmaraş, Turkey (Türkiye)
  • Şehit Hakan Duyğal Huzurevi Yaşlı Bakım ve Rehabilitasyon Merkezi
    Kahramanmaraş, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared with other researchers. This decision reflects the confidentiality commitments made during the institutional permission process and the protection of participants' privacy. Study findings will be reported in aggregate form without identifying individual participants.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2026 (actual). Primary completion is estimated for Dec 2026, 1 month after the start.

Of 3,483 non-industry interventional studies with no phase under Depression, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 41. This study's planned 1 month is below that.

Counting every sponsor, half of 3,581 studies reached it within 21 months; a quarter within 9 and three quarters within 41.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 14, 2026
First posted
Nov 19, 2026
StartActual
Oct 23, 2026
Primary completionEst.
Dec 15, 2026
CompletionEst.
Jan 15, 2027
Last update
Nov 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 19, 2026
Show all 1 update
  1. Nov 19, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07947719
Lead sponsor
Ataturk University
Responsible party
Mustafa ÇILGI (Doctoral Student, Ataturk University) — Principal investigator
First posted
Nov 19, 2026
Start date
Oct 23, 2026
Primary completion
Dec 15, 2026 (estimated)
Completion
Jan 15, 2027 (estimated)
Last update
Nov 19, 2026

Study contacts

Mustafa ÇILGI, MSc
study director · Ataturk University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion